Using Urinary Neutrophile Gelatinase-associated Lipocalin for Prognosticate Renal Dysfunction in Children with Familial Mediterranean Fever the Study Design: a Pilot Study

Overview

Journal Adv Rheumatol

Publisher Biomed Central

Specialty Rheumatology

Date 2021 Apr 2

PMID 33795029

Citations 1

Authors

Sinem Can Oksay

Hasan Dursun

Sebnem Tekin Neijmann

Sami Hatipoglu

Affiliations

Soon will be listed here.

Abstract

Background: The most important finding that affects the prognosis in Familial Mediterranean Fever is renal amyloidosis. The aim of the present study was to analyze neutrophil gelatinase-associated lipocalin levels in the urine, and to investigate whether it may be used as an early marker for renal involvement.

Methods: Forty attack-free children followed by diagnosis of Familial Mediterranean Fever with age range of 5 and 18 years, and 38 healthy children with similar ages and genders were enrolled into the study. Hemogram, sedimentation, C-reactive protein, urine analysis, creatinine in the spot urine, microalbumin and urinary neutrophil gelatinase-associated lipocalin levels were analyzed and evaluated statistically in the patients and controls.

Results: There was not any statistically significant difference between the patient and control groups for age, gender, height and body weight. Although there was not any clinical sign of attack in the patient group, sedimentation, C-reactive protein and fibrinogen levels were significantly higher than the control group (p = 0.002, p = 0.023, and p = 0.006, respectively). Similarly, urinary neutrophil gelatinase-associated lipocalin level and urinary creatinine ratio were significantly higher in the patient group (p = 0.0001, p = 0.011, respectively). We found a positive correlation between uNGAL level and uNGAL/uCr ratio and number of attacks per year in FMF patients (r = 0.743, p = 0.001 and r = 0.516, p = 0.001; respectively).

Conclusions: Detection of significantly higher levels of urinary neutrophil gelatinase-associated lipocalin level and urinary neutrophil gelatinase-associated lipocalin level to creatinine ratio were suggested as urinary neutrophil gelatinase-associated lipocalin level as a non-invasive marker for renal involvement better than microalbumin.

Citing Articles

Amyloidosis and Glomerular Diseases in Familial Mediterranean Fever.

Siligato R, Gembillo G, Calabrese V, Conti G, Santoro D Medicina (Kaunas). 2021; 57(10).

PMID: 34684086 PMC: 8541210. DOI: 10.3390/medicina57101049.

References

Ben-Chetrit E, Levy M . Familial Mediterranean fever. Lancet. 1998; 351(9103):659-64. DOI: 10.1016/S0140-6736(97)09408-7. View

Ozdogan H, Ugurlu S . Familial Mediterranean Fever. Presse Med. 2019; 48(1 Pt 2):e61-e76. DOI: 10.1016/j.lpm.2018.08.014. View

SOHAR E, Gafni J, Pras M, Heller H . Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med. 1967; 43(2):227-53. DOI: 10.1016/0002-9343(67)90167-2. View

Alghamdi M . Familial Mediterranean fever, review of the literature. Clin Rheumatol. 2017; 36(8):1707-1713. DOI: 10.1007/s10067-017-3715-5. View

Heller H, SOHAR E, Gafni J, Heller J . Amyloidosis in familial Mediterranean fever. An independent genetically determined character. Arch Intern Med. 1961; 107:539-50. DOI: 10.1001/archinte.1961.03620040065007. View

Saatci U, Ozen S, Ozdemir S, Bakkaloglu A, Besbas N, Topaloglu R . Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis. Eur J Pediatr. 1997; 156(8):619-23. DOI: 10.1007/s004310050677. View

Akpolat T, Ozkaya O, Ozen S . Homozygous M694V as a risk factor for amyloidosis in Turkish FMF patients. Gene. 2011; 492(1):285-9. DOI: 10.1016/j.gene.2011.10.012. View

Livneh A, Langevitz P, Shinar Y, Zaks N, Kastner D, Pras M . MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. Amyloid. 1999; 6(1):1-6. DOI: 10.3109/13506129908993281. View

Shohat M, Magal N, Shohat T, Chen X, Dagan T, Mimouni A . Phenotype-genotype correlation in familial Mediterranean fever: evidence for an association between Met694Val and amyloidosis. Eur J Hum Genet. 1999; 7(3):287-92. DOI: 10.1038/sj.ejhg.5200303. View

10.

Stojanovic K, Hentgen V, Fellahi S, Georgin-Lavialle S, Amselem S, Grateau G . Concordance between CRP and SAA in familial Mediterranean fever during attack-free period: A study of 218 patients. Clin Biochem. 2016; 50(4-5):206-209. DOI: 10.1016/j.clinbiochem.2016.11.008. View

11.

Erer B, Demirkaya E, Ozen S, Kallinich T . What is the best acute phase reactant for familial Mediterranean fever follow-up and its role in the prediction of complications? A systematic review. Rheumatol Int. 2015; 36(4):483-7. DOI: 10.1007/s00296-015-3413-z. View

12.

Anton P, Targan S, Vigna S, Durham M, SCHWABE A, Shanahan F . Enhanced neutrophil chemiluminescence in familial Mediterranean fever. J Clin Immunol. 1988; 8(2):148-56. DOI: 10.1007/BF00917903. View

13.

Saatci U, Ozdemir S, Ozen S, Bakkaloglu A . Serum concentration and urinary excretion of beta 2-microglobulin and microalbuminuria in familial Mediterranean fever. Arch Dis Child. 1994; 70(1):27-9. PMC: 1029677. DOI: 10.1136/adc.70.1.27. View

14.

Baskin E, Saatci U . Microalbuminuria in the course of familial Mediterranean fever. Nephrol Dial Transplant. 2004; 19(10):2678. DOI: 10.1093/ndt/gfh285. View

15.

Erguven M, Emeksiz C, Deveci M, Ozlu S . Relation between microalbuminuria and gene mutations in familial Mediterranean fever. Turk J Pediatr. 2008; 50(4):326-30. View

16.

Uslu A, Aydin B, Icagasioglu I, Balta S, Deveci K, Alkan F . The Relationship Among the Level of Serum Amyloid A, High-Density Lipoprotein and Microalbuminuria in Patients With Familial Mediterranean Fever. J Clin Lab Anal. 2016; 30(6):1003-1008. PMC: 6807140. DOI: 10.1002/jcla.21971. View

17.

Schmidt-Ott K, Mori K, Li J, Kalandadze A, Cohen D, Devarajan P . Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol. 2007; 18(2):407-13. DOI: 10.1681/ASN.2006080882. View

18.

Devarajan P . Biomarkers for the early detection of acute kidney injury. Curr Opin Pediatr. 2011; 23(2):194-200. PMC: 3257513. DOI: 10.1097/MOP.0b013e328343f4dd. View

19.

Bolignano D, Coppolino G, Lacquaniti A, Nicocia G, Buemi M . Pathological and prognostic value of urinary neutrophil gelatinase-associated lipocalin in macroproteinuric patients with worsening renal function. Kidney Blood Press Res. 2008; 31(4):274-9. DOI: 10.1159/000151665. View

20.

Bolignano D, Lacquaniti A, Coppolino G, Donato V, Campo S, Fazio M . Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol. 2009; 4(2):337-44. PMC: 2637601. DOI: 10.2215/CJN.03530708. View